NAB – The Morning Call · More positive vaccine news, but equities are cautious

More positive vaccine news, but equities are cautious

Tuesday 24th November 2020

Astra Zeneca announced the results of their trials, with efficacy up to 90 percent with a drug that is cheaper to produce and easier to distribute. Yet the markets were cautious in their response, although equities are on the rise and tech stocks are taking a back seat. NAB’s David de Garis talks through the response, with the US dollar also spurred on by better than expected Markit PMI numbers for the US. Donald Trump is still in the White House and trying to build a western alliance to play it tough against China, although the response has been somewhat muted.  The pound has strengthened on Brexit hopes even though there’s been no specific news. And it’s the Victoria budget today, with a focus on infrastructure spending.

Leave a Reply

Your email address will not be published.

Scroll to top